In Kuala Lumpur, several stocks are drawing attention due to significant developments. Duopharma Biotech Bhd has landed a three-year contract worth RM155.3 million from the Health Ministry to supply recombinant human insulin products and reusable insulin pens to government healthcare facilities, which is expected to positively impact earnings through June 2029. Dagang Nexchange Bhd (DNeX) has bolstered its energy portfolio by acquiring a 20% stake in TI Exploration & Production Sdn Bhd, enhancing its presence in Terengganu and the broader energy sector. Dayang Enterprise Holdings Bhd has entered a 50:50 joint venture with Brunei's Petrokon Utama Sdn Bhd to pursue maintenance and construction opportunities in Brunei's oil and gas sector, aligning with its strategy to expand regionally. Varia Bhd, through its subsidiary, has partnered with Seri Alam Properties to develop a RM250 million residential project in Bandar Seri Alam, Johor Bahru, featuring 645 apartment units. Lastly, Kee Ming Holdings Bhd has secured a RM21.36 million subcontract for electrical engineering works at a hyperscale data centre in Puncak Alam, which will enhance its order book and earnings visibility through the end of 2026.